Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
Clinical trial NCT02316899 · COMPLETED
Trial details
- NCT number
- NCT02316899
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-21
- Primary completion
- 2015-09-19
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.